Cluster composition

Functions

CategoryNameIntersectionWithQueryPValueGenesInTermGenesInQueryGenesInTermInQueryID
GeneOntologyMolecularFunctionX11-like protein binding

CLSTN3 CLSTN2

2.84e-053622GO:0042988
GeneOntologyMolecularFunctionFc-gamma receptor I complex binding

IGHG2 IGHG3

1.97e-047622GO:0034988
GeneOntologyMolecularFunctioncalcium ion binding

CLSTN3 DST SCUBE2 GALNT3 CANT1 CLSTN2 DNAH7 ITIH1 RYR1

4.79e-04749629GO:0005509
GeneOntologyCellularComponentpostsynaptic specialization membrane

CLSTN3 GRIK1 LRRC7 CLSTN2 CHRNA1

3.50e-04201635GO:0099634
GeneOntologyCellularComponentsynaptic membrane

CLSTN3 NRXN3 C1QA GRIK1 LRRC7 CLSTN2 CHRNA1 HTT

3.50e-04583638GO:0097060
MousePhenoincreased susceptibility to malignant hyperthermia

RYR1 HTT

1.20e-052492MP:0020214
MousePhenoimpaired skeletal muscle contractility

DST NEB RYR1 MYBPC2

1.63e-0544494MP:0002841
MousePhenoabsent memory B cells

IGHG2 IGHG3

7.19e-054492MP:0008094
DomainCalsyntenin

CLSTN3 CLSTN2

2.94e-053592IPR026914
DomainHAD-SF_hydro_IG_5-nucl

NT5C2 NT5DC1

5.86e-054592IPR008380
Domain5_nucleotid

NT5C2 NT5DC1

5.86e-054592PF05761
DomainVWA

INTS6 ITIH1 CFB

7.37e-0456593PF00092
DomainHATPase_c

MORC2 TOP2B

1.45e-0318592SM00387
DomainHATPase_c

MORC2 TOP2B

1.62e-0319592PF02518
Domain-

INTS6 ITIH1 CFB

1.66e-03745933.40.50.410
Domain-

MORC2 TOP2B

1.80e-03205923.30.565.10
DomainHATPase_C

MORC2 TOP2B

1.98e-0321592IPR003594
DomainVWFA

INTS6 ITIH1 CFB

2.22e-0382593PS50234
DomainVWA

INTS6 ITIH1 CFB

2.38e-0384593SM00327
Domain-

CLSTN3 NRXN3 CLSTN2

3.37e-03955932.60.120.200
DomainVWF_A

INTS6 ITIH1 CFB

3.79e-0399593IPR002035
DomainConA-like_dom

CLSTN3 NRXN3 CLSTN2 RYR1

5.06e-03219594IPR013320
PathwayREACTOME_INITIAL_TRIGGERING_OF_COMPLEMENT

IGHG2 IGHG3 C1QA CFB

2.12e-0554434MM14655
PathwayREACTOME_COMPLEMENT_CASCADE

IGHG2 IGHG3 C1QA CFB

1.21e-0484434MM14653
Pubmed

Enhanced analysis of the mouse plasma proteome using cysteine-containing tryptic glycopeptides.

EGFR IGHG2 IGHG3 ITIH1 CFB

7.70e-085963517330941
Pubmed

Complement activation selectively potentiates the pathogenicity of the IgG2b and IgG3 isotypes of a high affinity anti-erythrocyte autoantibody.

IGHG2 IGHG3 C1QA

3.15e-07863311901193
Pubmed

A protein interaction landscape of breast cancer.

CDKN1B DST SCUBE2 SND1 EGFR UBR4 OLA1 ARPC1B TOP2B

2.07e-0663463934591612
Pubmed

Cytoplasmic Metadherin (MTDH) provides survival advantage under conditions of stress by acting as RNA-binding protein.

SND1 EGFR IGHG2 IGHG3 NEB RYR1

2.57e-0621463622199357
Pubmed

Dynamic regulation of B cell complement signaling is integral to germinal center responses.

IGHG2 IGHG3 C1QA

3.12e-061663334031614
Pubmed

Involvement of the lectin pathway of complement activation in antimicrobial immune defense during experimental septic peritonitis.

C1QA CFB

3.23e-06263215322019
Pubmed

Temporary depletion of complement component C3 or genetic deficiency of C1q significantly delays onset of scrapie.

C1QA CFB

3.23e-06263211283677
Pubmed

Antibody-mediated glomerulonephritis in mice: the role of endotoxin, complement and genetic background.

C1QA CFB

3.23e-06263212930357
Pubmed

Mutant huntingtin regulates EGF receptor fate in non-neuronal cells lacking wild-type protein.

EGFR HTT

3.23e-06263222974559
Pubmed

Isolation and characterization of two growth factor-stimulated protein kinases that phosphorylate the epidermal growth factor receptor at threonine 669.

EGFR ELF3

3.23e-0626321651322
Pubmed

The human papillomavirus type 16 E5 oncoprotein synergizes with EGF-receptor signaling to enhance cell cycle progression and the down-regulation of p27(Kip1).

CDKN1B EGFR

3.23e-06263220144468
Pubmed

Nicotine induces resistance to erlotinib via cross-talk between α 1 nAChR and EGFR in the non-small cell lung cancer xenograft model.

EGFR CHRNA1

3.23e-06263225670150
Pubmed

Classical and alternative pathway complement activation are not required for reactive systemic AA amyloid deposition in mice.

C1QA CFB

3.23e-06263215147568
Pubmed

Lethal multiple pterygium syndrome, large cystic hygroma, and cleft palate: Rare and severe fetal presentations of RYR1- and NEB-related congenital myopathies.

NEB RYR1

3.23e-06263238520674
Pubmed

Essential role of factor B of the alternative complement pathway in complement activation and opsonophagocytosis during acute pneumococcal otitis media in mice.

C1QA CFB

9.68e-06363221502587
Pubmed

Skp2, p27kip1 and EGFR assessment in head and neck squamous cell carcinoma: prognostic implications.

CDKN1B EGFR

9.68e-06363218695910
Pubmed

The calsyntenins--a family of postsynaptic membrane proteins with distinct neuronal expression patterns.

CLSTN3 CLSTN2

9.68e-06363212498782
Pubmed

Additive inhibition of complement deposition by pneumolysin and PspA facilitates Streptococcus pneumoniae septicemia.

C1QA CFB

9.68e-06363216034123
Pubmed

Calsyntenin-3 interacts with the sodium-dependent vitamin C transporter-2 to regulate vitamin C uptake.

CLSTN3 CLSTN2

9.68e-06363234673103
Pubmed

Accelerated nephrotoxic nephritis is exacerbated in C1q-deficient mice.

C1QA CFB

9.68e-06363211359841
Pubmed

The role of complement in innate, adaptive and eosinophil-dependent immunity to the nematode Nippostrongylus brasiliensis.

C1QA CFB

9.68e-06363217675237
Pubmed

Cutting edge: C1q protects against the development of glomerulonephritis independently of C3 activation.

C1QA CFB

9.68e-06363210229798
Pubmed

Enhanced susceptibility to acute pneumococcal otitis media in mice deficient in complement C1qa, factor B, and factor B/C2.

C1QA CFB

9.68e-06363220065024
Pubmed

Prolonged cetuximab treatment promotes p27Kip1-mediated G1 arrest and autophagy in head and neck squamous cell carcinoma.

CDKN1B EGFR

9.68e-06363233664437
Pubmed

ELF3 Is a Target That Promotes Therapeutic Efficiency in EGFR Tyrosine Kinase Inhibitor-Resistant Non-Small Cell Lung Cancer Cells via Inhibiting PKCί.

EGFR ELF3

9.68e-06363234830169
Pubmed

Serum Levels of Complement Factors C1q, Bb, and H in Normal Pregnancy and Severe Pre-Eclampsia.

C1QA CFB

9.68e-06363231541546
Pubmed

The N-recognin UBR4 of the N-end rule pathway is required for neurogenesis and homeostasis of cell surface proteins.

EGFR UBR4

9.68e-06363230157281
Pubmed

An investigation into the human serum "interactome".

IGHG2 C1QA ITIH1 CFB IGDCC4

1.16e-0516263515174051
Pubmed

Proteome-wide characterization of N-glycosylation events by diagonal chromatography.

EGFR C1QA ITIH1 CFB

1.20e-057763416944957
Pubmed

Differential expression of paralog RNA binding proteins establishes a dynamic splicing program required for normal cerebral cortex development.

NRXN3 STXBP5L LRRC7

1.80e-052863338324473
Pubmed

Sequence analysis of cloned cDNA encoding part of an immunoglobulin heavy chain.

IGHG2 IGHG3

1.93e-054632113776
Pubmed

Highly specific anti-estradiol antibodies: structural characterisation and binding diversity.

IGHG2 IGHG3

1.93e-05463211812141
Pubmed

Multiple amino acid substitutions between murine gamma 2a heavy chain Fc regions of Ig1a and Ig1b allotypic forms.

IGHG2 IGHG3

1.93e-0546326794027
Pubmed

Further evidence that BALB/c and C57BL/6 gamma 2a genes originate from two distinct isotypes.

IGHG2 IGHG3

1.93e-0546322510996
Pubmed

Spontaneous deletions in Ig heavy chain genes: flanking sequences influence splice site selection.

IGHG2 IGHG3

1.93e-0546321754385
Pubmed

Sialic acid residues are essential for the anaphylactic activity of murine IgG1 antibodies.

IGHG2 IGHG3

1.93e-05463219050247
Pubmed

An autoimmune disease variant of IgG1 modulates B cell activation and differentiation.

IGHG2 IGHG3

1.93e-05463230287618
Pubmed

Switch transcripts in immunoglobulin class switching.

IGHG2 IGHG3

1.93e-0546327892607
Pubmed

Determination of the primary structure of a mouse G2a immunoglobulin. Identification of the disulfide bridges.

IGHG2 IGHG3

1.93e-0546324565406
Pubmed

IgG1 protects against renal disease in a mouse model of cryoglobulinaemia.

IGHG2 IGHG3

1.93e-05463225363774
Pubmed

Mutational deglycosylation of the Fc portion of immunoglobulin G causes O-sulfation of tyrosine adjacently preceding the originally glycosylated site.

IGHG2 IGHG3

1.93e-05463220621099
Pubmed

Antibody epitopes on the neuraminidase of a recent H3N2 influenza virus (A/Memphis/31/98).

IGHG2 IGHG3

1.93e-05463212414967
Pubmed

Shutdown of class switch recombination by deletion of a switch region control element.

IGHG2 IGHG3

1.93e-0546328438159
Pubmed

Passive anaphylaxis in mice with gamma-G antibodies. V. Competitive effects of different immunoglobulins and inhibition of reactions with antiglobulin sera.

IGHG2 IGHG3

1.93e-0546324098598
Pubmed

Mouse immunoglobulin genes: a bacterial plasmid containing the entire coding sequence for a pre-gamma 2a heavy chain.

IGHG2 IGHG3

1.93e-0546326253932
Pubmed

Continual low-level activation of the classical complement pathway.

C1QA CFB

1.93e-05463211560991
Pubmed

Immunoglobulin gamma 1 heavy chain gene: structural gene sequences cloned in a bacterial plasmid.

IGHG2 IGHG3

1.93e-0546326769752
Pubmed

Mouse immunoglobulin allotypes: post-duplication divergence of gamma 2a and gamma 2b chain genes.

IGHG2 IGHG3

1.93e-0546326803173
Pubmed

Linkage of the four gamma subclass heavy chain genes.

IGHG2 IGHG3

1.93e-0546326264445
Pubmed

Sequences near the 3' secretion-specific polyadenylation site influence levels of secretion-specific and membrane-specific IgG2b mRNA in myeloma cells.

IGHG2 IGHG3

1.93e-0546322878362
Pubmed

SH3 domain-dependent association of huntingtin with epidermal growth factor receptor signaling complexes.

EGFR HTT

1.93e-0546329079622
Pubmed

IgG1 deficiency exacerbates experimental autoimmune myasthenia gravis in BALB/c mice.

IGHG2 IGHG3

1.93e-05463225867470
Pubmed

Sequence of the gamma 2b membrane 3' untranslated region: polya site determination and comparison to the gamma 2a membrane 3' untranslated region.

IGHG2 IGHG3

1.93e-0546321542303
Pubmed

Switch of CD4+ T cell differentiation from Th2 to Th1 by treatment with cathepsin B inhibitor in experimental leishmaniasis.

IGHG2 IGHG3

1.93e-0546329725203
Pubmed

Nucleotide sequences of all the gamma gene loci of murine immunoglobulin heavy chains.

IGHG2 IGHG3

1.93e-0546329126488
Pubmed

The IL-4 induced increase in the frequency of resting murine splenic B cells expressing germline Ig heavy chain gamma 1 transcripts correlates with subsequent switching to IgG1.

IGHG2 IGHG3

1.93e-0546328452816
Pubmed

Roles of the alternative complement pathway and C1q during innate immunity to Streptococcus pyogenes.

C1QA CFB

1.93e-05463216670320
Pubmed

Determination of the primary structure of a mouse IgG2a immunoglobulin:amino-acid sequence of the Fc fragment. Implications for the evolution of immunoglobulin structure and function.

IGHG2 IGHG3

1.93e-0546324831970
Pubmed

Nucleotide sequences of class-switch recombination region of the mouse immunoglobulin gamma 2b-chain gene.

IGHG2 IGHG3

1.93e-0546327439686
Pubmed

On immunoglobulin heavy chain gene switching: two gamma 2b genes are rearranged via switch sequences in MPC-11 cells but only one is expressed.

IGHG2 IGHG3

1.93e-0546326278424
Pubmed

An Asia-specific variant of human IgG1 represses colorectal tumorigenesis by shaping the tumor microenvironment.

IGHG2 IGHG3

1.93e-05463235133976
Pubmed

Restriction fragment length polymorphism and evolution of the mouse immunoglobulin constant region gamma loci.

IGHG2 IGHG3

1.93e-0546328099342
Pubmed

Ubiquitination of IgG1 cytoplasmic tail modulates B-cell signalling and activation.

IGHG2 IGHG3

1.93e-05463232006024
Pubmed

Strong antigenic selection shaping the immunoglobulin heavy chain repertoire of B-1a lymphocytes in lambda 2(315) transgenic mice.

IGHG2 IGHG3

1.93e-05463212209645
Pubmed

Sequence of the cloned gene for the constant region of murine gamma 2b immunoglobulin heavy chain.

IGHG2 IGHG3

1.93e-054632117549
Pubmed

Impaired opsonization with C3b and phagocytosis of Streptococcus pneumoniae in sera from subjects with defects in the classical complement pathway.

C1QA CFB

1.93e-05463218541650
Pubmed

Cloning immunoglobulin gamma 2b chain gene of mouse: characterization and partial sequence determination.

IGHG2 IGHG3

1.93e-054632116231
Pubmed

Highly reduced binding to high and low affinity mouse Fc gamma receptors by L234A/L235A and N297A Fc mutations engineered into mouse IgG2a.

IGHG2 IGHG3

1.93e-05463225451975
Pubmed

Nucleotide sequences of gene segments encoding membrane domains of immunoglobulin gamma chains.

IGHG2 IGHG3

1.93e-0546326283537
Pubmed

Somatic mutation in genes for the variable portion of the immunoglobulin heavy chain.

IGHG2 IGHG3

1.93e-0546326801765
Pubmed

Immunoglobulin diversity: analysis of the germ-line VH gene repertoire of the murine anti-GAT response.

IGHG2 IGHG3

1.93e-0546326306571
Pubmed

The molecular and biochemical characterization of mutant monoclonal antibodies with increased antigen binding.

IGHG2 IGHG3

1.93e-0546321672339
Pubmed

Recognition of a cell-surface oligosaccharide of pathogenic Salmonella by an antibody Fab fragment.

IGHG2 IGHG3

1.93e-0546321713710
Pubmed

Structure of the constant and 3' untranslated regions of the murine Balb/c gamma 2a heavy chain messenger RNA.

IGHG2 IGHG3

1.93e-0546326777755
Pubmed

The roles of gamma 1 heavy chain membrane expression and cytoplasmic tail in IgG1 responses.

IGHG2 IGHG3

1.93e-0546329103199
Pubmed

Gene conversion and polymorphism: generation of mouse immunoglobulin gamma 2a chain alleles by differential gene conversion by gamma 2b chain gene.

IGHG2 IGHG3

1.93e-0546326297797
Pubmed

Evolution of immunoglobulin subclasses. Primary structure of a murine myeloma gamma1 chain.

IGHG2 IGHG3

1.93e-05463298524
Pubmed

Mannose binding lectin is required for alphavirus-induced arthritis/myositis.

C1QA CFB

1.93e-05463222457620
Pubmed

Immunoglobulin heavy constant gamma 1 silencing decreases tonicity-responsive enhancer-binding protein expression to alleviate diabetic nephropathy.

IGHG2 IGHG3

1.93e-05463238268239
Pubmed

Conditional mutagenesis in mice with heat shock promoter-driven cre transgenes.

EGFR HTT

1.93e-05463210723724
Pubmed

Gene segments encoding transmembrane carboxyl termini of immunoglobulin gamma chains.

IGHG2 IGHG3

1.93e-0546326799207
Pubmed

Comparison of mouse immunoglobulin gamma 2a and gamma 2b chain genes suggests that exons can be exchanged between genes in a multigenic family.

IGHG2 IGHG3

1.93e-0546326787604
Pubmed

Multiple differences between the nucleic acid sequences of the IgG2aa and IgG2ab alleles of the mouse.

IGHG2 IGHG3

1.93e-0546326170065
Pubmed

Genetic variants in the immunoglobulin heavy chain locus are associated with the IgG index in multiple sclerosis.

IGHG2 IGHG3

1.93e-05463223225573
Pubmed

Distinction of the memory B cell response to cognate antigen versus bystander inflammatory signals.

IGHG2 IGHG3

1.93e-05463219703988
Pubmed

Gastrointestinal ischemia-reperfusion injury is lectin complement pathway dependent without involving C1q.

C1QA CFB

1.93e-05463215879138
Pubmed

The alternative pathway is required, but not alone sufficient, for retinal pathology in mouse laser-induced choroidal neovascularization.

C1QA CFB

1.93e-05463221257205
Pubmed

Rearrangement of immunoglobulin gamma 1-chain gene and mechanism for heavy-chain class switch.

IGHG2 IGHG3

1.93e-0546326767246
Pubmed

Determination of the interface of a large protein complex by transferred cross-saturation measurements.

IGHG2 IGHG3

1.93e-05463212051834
Pubmed

The gamma 1 heavy chain gene includes all of the cis-acting elements necessary for expression of properly regulated germ-line transcripts.

IGHG2 IGHG3

1.93e-0546328683112
Pubmed

Genes for immunoglobulin heavy chain and serum prealbumin protein are linked in mouse.

IGHG2 IGHG3

1.93e-054632807855
Pubmed

Identification of a gene locus for gamma-G-1 immunoglobulin H chains and its linkage to the H chain chromosome region in the mouse.

IGHG2 IGHG3

1.93e-0546324166666
Pubmed

Deletion of the complement C5a receptor alleviates the severity of acute pneumococcal otitis media following influenza A virus infection in mice.

C1QA CFB

1.93e-05463224740152
Pubmed

Multiple B-cell epitope vaccine induces a Staphylococcus enterotoxin B-specific IgG1 protective response against MRSA infection.

IGHG2 IGHG3

1.93e-05463226201558
Pubmed

HER2+ Cancer Cell Dependence on PI3K vs. MAPK Signaling Axes Is Determined by Expression of EGFR, ERBB3 and CDKN1B.

CDKN1B EGFR

1.93e-05463227035903
Pubmed

Molecular cloning of mouse immunoglobulin heavy chain messenger ribonucleic acids coding for mu, alpha, gamma 1, gamma 2a, and gamma 3 chains.

IGHG2 IGHG3

1.93e-0546326249338
Pubmed

FKBP3 Promotes Proliferation of Non-Small Cell Lung Cancer Cells through Regulating Sp1/HDAC2/p27.

CDKN1B FKBP3

1.93e-05463228839465
Pubmed

mRNA for surface immunoglobulin gamma chains encodes a highly conserved transmembrane sequence and a 28-residue intracellular domain.

IGHG2 IGHG3

1.93e-0546326804950
Pubmed

Integrin-dependent organization and bidirectional vesicular traffic at cytotoxic immune synapses.

IGHG2 IGHG3

1.93e-05463219592272
Pubmed

The alternative complement pathway propagates inflammation and injury in murine ischemic stroke.

C1QA CFB

1.93e-05463223028050
GeneFamilyCadherin related

CLSTN3 CLSTN2

6.36e-041740224
ToppCellMid-temporal_gyrus_(MTG)-Neuronal-Inh_GABAergic-i_Gaba_2-GABA_VIP_2-Inh_L1-3_VIP_ZNF322P1|Mid-temporal_gyrus_(MTG) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types

ENOSF1 EGFR KLHL13 GRIK1 IGDCC4

6.45e-061856350b5a0df58ae2ad8261f40f152775747af4f3937a
ToppCellSubstantia_nigra-Neuronal|Substantia_nigra / BrainAtlas - Mouse McCarroll V32

CLSTN3 NRXN3 LRRC7 CLSTN2 TTC3

6.62e-061866353f889083fcffe516388e9b03a5e23af2010ced33
ToppCell10x3'2.3-week_17-19-Mesenchymal_myocytic-stroma-myofibroblast|week_17-19 / cell types per 3 fetal stages;per 3',per 5'

EGFR KLHL13 ADAMTS14 NEB CHRNA1

7.92e-0619363502dfd1df1e7fc84bfca2b0c95138b5b4408bb5d1
ToppCell10x3'2.3-week_17-19-Mesenchymal_myocytic-stroma-muscle_stem_cell|week_17-19 / cell types per 3 fetal stages;per 3',per 5'

EGFR KLHL13 NEB CHRNA1 IGDCC4

8.97e-0619863555e583321f60c95898d93cd0d2615c6692db52ec
ToppCellNeuron-Postmitotic-Excitatory_Neuron_-Newborn-35|World / Primary Cells by Cluster

BPTF NRXN3 LRRC7 TTC3 TOP2B

8.97e-06198635de5214a85fe017eb23d4aa8af624464f062ec57e
ToppCell10x3'2.3-week_17-19-Mesenchymal_myocytic-stroma|week_17-19 / cell types per 3 fetal stages;per 3',per 5'

EGFR KLHL13 NEB CHRNA1 IGDCC4

9.19e-06199635e19b296d583f8bad3b66ee998a8153634d6fe09e
ToppCell10x3'2.3-week_17-19-Mesenchymal_myocytic|week_17-19 / cell types per 3 fetal stages;per 3',per 5'

EGFR KLHL13 NEB CHRNA1 IGDCC4

9.19e-06199635801887db51ac5dc5b068808ff75e3a46643398e9
ToppCellBrain_organoid-organoid_Tanaka_cellReport-3m-Neuronal-Interneuron|3m / Sample Type, Dataset, Time_group, and Cell type.

NRXN3 DST STXBP5L TTC3 TOP2B

9.41e-06200635a313b9a8bde1ea80a6eae183b76fba46b86558b4
ToppCellBrain_organoid-organoid_Tanaka_cellReport-6m-Mesenchymal-Mesoderm|6m / Sample Type, Dataset, Time_group, and Cell type.

CLSTN2 NEB CHRNA1 RYR1 MYBPC2

9.41e-062006350f6851baf0cf2a8b0c95a7a585c4407c330c5f6c
ToppCellLPS-IL1RA+antiTNF-Epithelial_alveolar-AT_1-Differentiating_AT2|LPS-IL1RA+antiTNF / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2

NRXN3 EGFR BZW2 ELF3

3.80e-051336345bf5e654653e2c340891f51e3f2a30441b7b6b2b
ToppCellCOVID-19-Heart-CM_5_(RYR2-)|COVID-19 / Disease (COVID-19 only), tissue and cell type

NEB CHRNA1 RYR1 MYBPC2

5.18e-05144634f92e03dd784e31a9e5dbd4f4c3a6517ea19210cf
ToppCellTCGA-Bladder-Primary_Tumor-Urothelial_Carcinoma-Non-Papillary_Muscle_Invasive_Urothelial_Carcinoma-8|TCGA-Bladder / Sample_Type by Project: Shred V9

FER1L4 ZNF799 ZNF443 TOP2B

6.07e-051506341aa9320d97ff10994ea024751790524fe133aba9
ToppCell367C-Myeloid-Macrophage-FABP4+_Macrophage_2|Myeloid / Donor, Lineage, Cell class and subclass (all cells)

DST SCUBE2 EGFR DNAH7

6.72e-051546346c1e7682c43c40b58b371c58deb10b839700ebcc
ToppCellmetastatic_Brain-Myeloid_cells-Undetermined|Myeloid_cells / Location, Cell class and cell subclass

IGHG3 HSD17B6 C1QA ZNF443

7.24e-051576346ce7f2ea613e7f8e771860e8c0512274e4f54369
ToppCellkidney_cells-Adult_normal_reference-Immune-Lymphocytic_B-Plasma_Cell|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group

IGHG2 IGHG3 FER1L4 HSD17B6

8.18e-05162634ee6f05620f4f4ebbebd5b098afc7c20876e3d21f
ToppCellkidney_cells-Adult_normal_reference-Immune-Lymphocytic_B-Plasma_Cell-|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group

IGHG2 IGHG3 FER1L4 HSD17B6

8.18e-051626349e72d468fcdd0d27b517a9e36efb35d4617a88f9
ToppCelldroplet-Marrow-BM-30m-Myeloid-basophil|Marrow / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation

UBE2O UBR4 COQ10B HECA

8.18e-0516263475df7ff779a3b9159ba97d852da1f8df650b9ce5
ToppCellfacs-Kidney-nan-3m-Lymphocytic|Kidney / Skin_Bladder_Kidney_Mammary_Gland - method, tissue, subtissue, age, lineage, cell ontology and free annotation

CDKN1B GRIK1 CLSTN2 ADAMTS14

8.78e-05165634ba041deb0d9c187f251493ccd4794b5f09abd5aa
ToppCelldroplet-Heart-HEART_(LV+RV_ONLY)-30m-Hematologic-red_blood_cell|Heart / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation

UBE2O SCUBE2 CLSTN2 RHD

8.78e-0516563462dd54dfbec7f43a41546a1fec719545c2608a36
ToppCellCOVID-19-Heart-T_cell|COVID-19 / Disease (COVID-19 only), tissue and cell type

STXBP5L NEB CHRNA1 RYR1

1.01e-04171634b2e753e811a7639956994609f73efcdb62d04f82
ToppCellLPS_only-Epithelial_alveolar-AT_2-Differentiating_AT2|LPS_only / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2

NRXN3 EGFR ELF3 CLSTN2

1.20e-04179634fd2cbee532e7b44113410dca82aec7db1a7fb69f
ToppCellLPS_only-Epithelial_alveolar-AT_2-AT2_Progenitor|LPS_only / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2

NRXN3 EGFR ELF3 CLSTN2

1.25e-041816340513b9e6673ff7bf8e72ba123ca3794b65d10170
ToppCellLPS-IL1RA+antiTNF-Epithelial_alveolar-AT_2|LPS-IL1RA+antiTNF / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2

NRXN3 EGFR BZW2 ELF3

1.28e-0418263417ed11a7ea366dd3106400511d5e628d3f1a9c3e
ToppCell3'-GW_trimst-1-LargeIntestine-Neuronal-Glial_immature-Glia_1_(DHH+)|GW_trimst-1 / Celltypes from developing, pediatric, Crohn's, & adult GI tract

DST GRIK1 CLSTN2 ARPC1B

1.31e-04183634547b1fb9f9940cfc8d6e351d96acc0da44def57e
ToppCellLPS-antiTNF-Epithelial_alveolar-AT_2-Differentiating_AT2|LPS-antiTNF / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2

NRXN3 EGFR ELF3 CLSTN2

1.34e-04184634ab2f06906fc7a9931dfa0864ef506832b07fb93e
ToppCellMid-temporal_gyrus_(MTG)-Neuronal-Inh_GABAergic-i_Gaba_2-GABA_VIP_1|Mid-temporal_gyrus_(MTG) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types

EGFR KLHL13 GRIK1 IGDCC4

1.36e-0418563408fad1e3c3cc5f1c3eb6629a49c094b628e75a92
ToppCellfacs-Brain_Non-Myeloid-Cerebellum-24m-Neuronal-interneuron|Brain_Non-Myeloid / Brain_Non-Myeloid_Brain_Myeloid - method, tissue, subtissue, age, lineage, cell ontology and free annotation

CLSTN3 NRXN3 STXBP5L TTC3

1.39e-04186634d1d01ce46e62944aa9864eda47e8401b5f0d2bdc
ToppCellSubstantia_nigra-Neuronal-Inhibitory|Substantia_nigra / BrainAtlas - Mouse McCarroll V32

CLSTN3 NRXN3 CLSTN2 TTC3

1.39e-041866349d3efe2a4feea2bc205a7e45b9b9f9ed9b3609ce
ToppCellLPS-IL1RA+antiTNF-Epithelial_alveolar-AT_2-Differentiating_AT2|LPS-IL1RA+antiTNF / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2

NRXN3 EGFR BZW2 ELF3

1.39e-04186634e83718fabb057100835d3357df407f283d23fe16
ToppCellMid-temporal_gyrus_(MTG)-Neuronal-Inh_GABAergic-i_Gaba_2-GABA_VIP_1-Inh_L1_ADARB2_ADAM33|Mid-temporal_gyrus_(MTG) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types

EGFR KLHL13 GRIK1 IGDCC4

1.42e-0418763402105c82a9ba79d2f19e002188377fc3440770c2
ToppCellLPS-IL1RA-Epithelial_alveolar-AT_2-Differentiating_AT2|LPS-IL1RA / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2

NRXN3 EGFR ELF3 CLSTN2

1.45e-041886344bdf8d49af0e9da349b16e3f012e1b0eec04cc4f
ToppCellCOVID-19-Epithelial-Ionocytes|COVID-19 / Condition, Lineage and Cell class

SCUBE2 EGFR ELF3 GRIK1

1.45e-04188634a581cb9528d0febbf3addbb4f6bc140f91a584e6
ToppCellwk_08-11-Epithelial-PNS-intermediate_Schwann|wk_08-11 / Celltypes from embryonic and fetal-stage human lung

NRXN3 KLHL13 CLSTN2 ARPC1B

1.45e-041886343f3a744b2615bf72f6119f26087099110c0d21fc
ToppCellControl-B_intermediate-6|Control / disease group and sub_cluster of B and Plasma cells(res = 0.5)

IGHG2 IGHG3 UBR4 ARPC1B

1.48e-0418963411cb9a16f1de8f60af2073ed7ea6d4f41c02f299
ToppCellrenal_medulla_nuclei-Adult_normal_reference-Epithelial-Intermediate_tubule_epithelial_cell-kidney_loop_of_Henle_thick_ascending_limb_epithelial_cell|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group

DST KLHL13 ELF3 IGDCC4

1.48e-04189634aadb7a2de4cbe7f0958651f2739bba430b93f5c1
ToppCellrenal_medulla_nuclei-Adult_normal_reference-Epithelial-Intermediate_tubule_epithelial_cell-kidney_loop_of_Henle_thick_ascending_limb_epithelial_cell-Adaptive_/_Maladaptive_/_Repairing_Thick_Ascending_Limb_Cell|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group

DST KLHL13 ELF3 IGDCC4

1.48e-041896348977f3295b7df7c7474b3f371de90a82ae4bb50c
ToppCellGlobus_pallidus-Neuronal|Globus_pallidus / BrainAtlas - Mouse McCarroll V32

CLSTN3 NRXN3 LRRC7 TTC3

1.51e-04190634416de85d8841dac883faa6f5339b2fb461a09e82
ToppCellPBMC_fresh-frozen-Severe-critical_progression_d03-09-Lymphocytic-Lymphocytic_B-B_cell-B_c03-CD27-AIM2|Severe-critical_progression_d03-09 / Compartment, severity and other cell annotations on 10x 3' data (130k)

IGHG2 IGHG3 CHRNA1 MYBPC2

1.51e-041906340db545a4cba7534bad2693e0d565cde7dbc7a586
ToppCellEntopeduncular-Neuronal-Inhibitory-iN1(Gad1Gad2_Th)|Entopeduncular / BrainAtlas - Mouse McCarroll V32

CLSTN3 NRXN3 PLCL2 TTC3

1.54e-041916345d24022cec293bc8d9e978ae99a109e660bb8f83
ToppCellEntopeduncular-Neuronal-Inhibitory|Entopeduncular / BrainAtlas - Mouse McCarroll V32

CLSTN3 NRXN3 PLCL2 TTC3

1.54e-0419163473dae4cdea86aec62393ad7303dc7375a6b3fc86
ToppCellMid-temporal_gyrus_(MTG)-Neuronal-Inh_GABAergic-i_Gaba_2|Mid-temporal_gyrus_(MTG) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types

EGFR KLHL13 GRIK1 IGDCC4

1.57e-041926343abee376c37c3646da33ac381aa63d50a01607a6
ToppCelldroplet-Fat-Scat-18m-Epithelial-nan|Fat / Fat_BAT_GAT_MAT_SCAT - method, tissue, subtissue, age, lineage, cell ontology and free annotation

NRXN3 GALNT3 FER1L4 ELF3

1.57e-041926344098b5170c9995718758a082d1b8bcb86d5a289e
ToppCelldroplet-Fat-Scat-18m-Epithelial|Fat / Fat_BAT_GAT_MAT_SCAT - method, tissue, subtissue, age, lineage, cell ontology and free annotation

NRXN3 GALNT3 FER1L4 ELF3

1.57e-04192634936028fe851e8dd2b906df0210acc574c017b499
ToppCelldroplet-Fat-Scat-18m-Epithelial-epithelial_cell|Fat / Fat_BAT_GAT_MAT_SCAT - method, tissue, subtissue, age, lineage, cell ontology and free annotation

NRXN3 GALNT3 FER1L4 ELF3

1.57e-0419263462e55ed0d46b2e7b07dc42399972a099576cbc5f
ToppCell10x_3'_v3-lymph_node_(10x_3'_v3)-myeloid-myeloid_dendritic|lymph_node_(10x_3'_v3) / Per Platform+tissue_group, by lineage_subgroup, cell_group, cell_type

DST SCUBE2 C1QA ITIH1

1.57e-04192634e24a8856ef01ccf69a5e968bd409f9b84befa91e
ToppCellfacs-Brain_Non-Myeloid-Cortex-3m-Neuronal-neuron|Brain_Non-Myeloid / Brain_Non-Myeloid_Brain_Myeloid - method, tissue, subtissue, age, lineage, cell ontology and free annotation

CLSTN3 PLCL2 LRRC7 CLSTN2

1.60e-04193634461919ab422bc9d1fcff7a3a4757c75239041d7e
ToppCellfacs-Brain_Non-Myeloid-Cortex-3m-Neuronal-nan|Brain_Non-Myeloid / Brain_Non-Myeloid_Brain_Myeloid - method, tissue, subtissue, age, lineage, cell ontology and free annotation

CLSTN3 PLCL2 LRRC7 CLSTN2

1.60e-041936340dd810ad900d3e586551622b2c1de39d76fd6a7f
ToppCell3'-Child04-06-SmallIntestine-Epithelial-goblet-Goblet_cell|Child04-06 / Celltypes from developing, pediatric, Crohn's, & adult GI tract

DST GALNT3 CANT1 ELF3

1.64e-0419463449cc5f5de4380302100e8cd937f08abe317ac75e
ToppCelldroplet-Pancreas-Endocrine-21m|Pancreas / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation

DST UBR4 C1QA NEB

1.64e-041946343a3ecedcdc7691cf21775818b598208fcb980c29
ToppCell3'-Child04-06-SmallIntestine-Epithelial-goblet|Child04-06 / Celltypes from developing, pediatric, Crohn's, & adult GI tract

DST GALNT3 CANT1 ELF3

1.64e-04194634fb935df966c451e659b8bde281f8aebcb632f6cf
ToppCellfacs-Brain_Non-Myeloid-Cortex-3m-Neuronal|Brain_Non-Myeloid / Brain_Non-Myeloid_Brain_Myeloid - method, tissue, subtissue, age, lineage, cell ontology and free annotation

CLSTN3 PLCL2 LRRC7 CLSTN2

1.67e-04195634ffbab350e67d9c4b66c0ab84550daec8b8139a27
ToppCellNeuron-Postmitotic-Excitatory_Neuron_-Cajal_Retzius-36|World / Primary Cells by Cluster

DST EGFR KLHL13 CLSTN2

1.67e-04195634bc76a0586cc78f013cb96a2444e63e3c5daa3bc7
ToppCellNeuron-Postmitotic-Excitatory_Neuron_-Cajal_Retzius|World / Primary Cells by Cluster

DST EGFR KLHL13 CLSTN2

1.67e-04195634424d8e2bc7f7e68f74219de06dbbb671c8b4c24c
ToppCellPrimary_Visual_cortex_(V1C)-Neuronal-Glutamatergic_Excit|Primary_Visual_cortex_(V1C) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types

STXBP5L VPS13A LRRC7 CLSTN2

1.67e-041956342e1df01bf6e4e98e6cd9fb50926e34c5077b8666
ToppCellsaliva-Mild-Moderate_progression_d12-25-Lymphocytic-Lymphocytic_B-B_cell-B_c02-MS4A1-CD27|Mild-Moderate_progression_d12-25 / Compartment, severity and other cell annotations on 10x 3' data (130k)

SND1 BZW2 IGHG3 LRRC7

1.70e-041966340175b097ad1338a07afebe3b5c7fd0bb0bb950f7
ToppCellfrontal_cortex-Neuronal|frontal_cortex / Per Region, Lineage, Cell class, Cell type, Cell subtype

CLSTN3 NRXN3 OLA1 TTC3

1.70e-04196634de7d10da862f98894ce47244fbc992f4a12d63bb
ToppCellControl-B_memory-3|Control / disease group and sub_cluster of B and Plasma cells(res = 0.5)

SND1 IGHG2 IGHG3 CHRNA1

1.74e-04197634b86385c6c1d52ef4e3d855004d77afab61556978
ToppCell3'-GW_trimst-1.5-SmallIntestine-Neuronal-Glial_immature-Glia_3_(BCAN+)|GW_trimst-1.5 / Celltypes from developing, pediatric, Crohn's, & adult GI tract

NRXN3 DST BZW2 ARPC1B

1.74e-041976341018aac22659c081d227d566afa29b1748c18ade
ToppCellBronchus_Control_(B.)-Epithelial-TX-Basal_1|Bronchus_Control_(B.) / Sample group, Lineage and Cell type

DST SCUBE2 EGFR GRIK1

1.77e-04198634f632342e1e8911dd82b5df171776a84c7dc3f931
ToppCellSomatosensory_Cortex_(S1)-Neuronal|Somatosensory_Cortex_(S1) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types

NRXN3 STXBP5L LRRC7 TTC3

1.77e-04198634c01091ef18e096d792ea2a7a715764a5b215355f
ToppCell5'-GW_trimst-1.5-SmallIntestine-Neuronal-Glial_immature|GW_trimst-1.5 / Celltypes from developing, pediatric, Crohn's, & adult GI tract

NRXN3 DST BZW2 ARPC1B

1.77e-0419863436c97eb71b89bac01cabd6a8b728e5a20e52d2a3
ToppCellLPS_IL1RA-Epithelial_alveolar-AT_2-Differentiating_AT2|LPS_IL1RA / Treatment groups by lineage, cell group, cell type

NRXN3 GALNT3 EGFR ELF3

1.77e-04198634285f729140b1df029c24f6ca1d2438470ac51794
ToppCellprimary_auditory_cortex_(A1C)-Neuronal|primary_auditory_cortex_(A1C) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types

NRXN3 STXBP5L LRRC7 TTC3

1.77e-041986346d18b45eda4014759e6dd282d78ffd28df8a6044
ToppCellAnterior_Cingulate_gyrus_(CgG)-Neuronal|Anterior_Cingulate_gyrus_(CgG) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types

NRXN3 STXBP5L LRRC7 TTC3

1.77e-041986340ff30edfd3c133a42e8cb96e1631a1143215f808
ToppCellerythropoietic-Basophilic_Erythroblast|erythropoietic / Lineage and Cell class

BZW2 TTC3 ARPC1B TOP2B

1.80e-0419963439c4adef3e02f948414f866aa22ac76f44b7b7db
ToppCellFrontal_cortex-Neuronal|Frontal_cortex / BrainAtlas - Mouse McCarroll V32

CLSTN3 UBE2O NRXN3 TTC3

1.80e-04199634f88039d862f3bfa01dc39d2de4f3f548dc5a0e61
ToppCelldistal-Epithelial-Club-1|distal / Location, Lineage, Cell class (ontology) and Donor from 10X sequencing (macrophage renamed)

SCUBE2 STXBP5L HSD17B6 ELF3

1.80e-04199634685cefbe6ff5db8b578e50b5849524ac2f347d0c
ToppCellLung_Parenchyma-Severe-Epithelial-Epithelial-Basal_3-|Severe / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.01)

DST EGFR ELF3 RYR1

1.84e-0420063441705bbba40eb5ddca0b223191aac1bce00163b8
ToppCellkidney_cells-Hypertensive_with+without-CKD-Epithelial-Intermediate_tubule_epithelial_cell-kidney_loop_of_Henle_thick_ascending_limb_epithelial_cell-Adaptive_/_Maladaptive_/_Repairing_Thick_Ascending_Limb_Cell|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group

DST GALNT3 KLHL13 ELF3

1.84e-04200634741e59c68ae4a3a7be830e98771a14f920c9e883
ToppCellNeuronal-Inhibitory-iA-iA_1(SST_PAX6)-SST-BAGE2|Neuronal / cells hierarchy compared to all cells using T-Statistic

EGFR KLHL13 GRIK1 IGDCC4

1.84e-0420063426f07d271e984f375145e4c10528fba44a5811e1
ToppCellNeuronal-Inhibitory-iA-iA_1(SST_PAX6)-SST-BAGE2-L1-2|Neuronal / cells hierarchy compared to all cells using T-Statistic

EGFR KLHL13 GRIK1 IGDCC4

1.84e-04200634c3637827ceba16b0d7956c280dd2ddbc8b1ba55e
ToppCellkidney_cells-Hypertensive_with+without-CKD-Epithelial-Intermediate_tubule_epithelial_cell-kidney_loop_of_Henle_thick_ascending_limb_epithelial_cell|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group

DST GALNT3 KLHL13 ELF3

1.84e-0420063455b7b17f2d413b9ebb262ef8bd210ef45618a7f3
ToppCellParenchyma_COVID-19-Epithelial-TX-Basal_3|Parenchyma_COVID-19 / Sample group, Lineage and Cell type

DST EGFR ELF3 RYR1

1.84e-0420063453e04399d0308b40ae99fbfaa4ff62bf061822d8
ToppCellParenchyma_COVID-19-Epithelial-TX-Basal_1|Parenchyma_COVID-19 / Sample group, Lineage and Cell type

DST EGFR ELF3 RYR1

1.84e-04200634592c7c3ded409a9957cbcdc62fcc213fa8eae598
ToppCell5'-GW_trimst-1.5-SmallIntestine-Neuronal-Glial_immature-ENCC/glia_Progenitor|GW_trimst-1.5 / Celltypes from developing, pediatric, Crohn's, & adult GI tract

NRXN3 DST BZW2 ARPC1B

1.84e-04200634de55100e98d3e9b8a74e37aebcd3afa2b0996527
ToppCellBrain_organoid-organoid_Tanaka_cellReport-3m-Mesenchymal-Mesoderm|3m / Sample Type, Dataset, Time_group, and Cell type.

NEB CHRNA1 RYR1 MYBPC2

1.84e-04200634538ae964db58c4acafe93f735b3e03fc08fdaac6
ToppCellLung_Parenchyma-Severe-Epithelial-Epithelial-Basal_3|Severe / Location, Disease Group, Cell group, Cell class (2021.03.09)

DST EGFR ELF3 RYR1

1.84e-04200634cc8df398532c9324fd3e171000b1ea5c208cd691
ToppCellLung_Parenchyma-Severe-Epithelial-Epithelial-Basal_1-|Severe / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.01)

DST EGFR ELF3 RYR1

1.84e-042006348cfbde43c5e66269ad128aa5398b1517667d7d36
ToppCellNeuronal-Inhibitory-iA-iA_1(SST_PAX6)-SST|Neuronal / cells hierarchy compared to all cells using T-Statistic

EGFR KLHL13 GRIK1 IGDCC4

1.84e-0420063453d5e427f0cbf5cf0b63efe4ec01da302f555704
ToppCellLung_Parenchyma-Severe-Epithelial-Epithelial-Basal_1|Severe / Location, Disease Group, Cell group, Cell class (2021.03.09)

DST EGFR ELF3 RYR1

1.84e-0420063461811380d9252f12f27b7ad4752380b52692677f
ComputationalGenes upregulated in subsets of cells of a given type within various tumors

BPTF DST NEB TTC3

3.41e-0549414GAVISH_3CA_MALIGNANT_METAPROGRAM_41_UNASSIGNED
ComputationalNeighborhood of TTN

NEB RYR1 MYBPC2

1.26e-0426413GNF2_TTN
DiseaseMULTIPLE PTERYGIUM SYNDROME, LETHAL TYPE

NEB CHRNA1 RYR1

1.67e-076613C1854678
Diseasetrem-like transcript 4 protein measurement

IGHG3 ITIH1

2.52e-054612EFO_0802160
DiseaseRING finger protein 165 measurement

IGHG3 ITIH1

2.52e-054612EFO_0802027
Diseasepotassium voltage-gated channel subfamily E member 2 measurement

IGHG3 ITIH1

4.19e-055612EFO_0801901
Diseaseprotein shisa-3 homolog measurement

IGHG3 ITIH1

4.19e-055612EFO_0801964
Diseasecarcinoembryonic antigen-related cell adhesion molecule 1 measurement

IGHG3 ITIH1

6.27e-056612EFO_0801456
Diseasebeta-sarcoglycan measurement

IGHG3 ITIH1

6.27e-056612EFO_0801422
Diseasemultiple coagulation factor deficiency protein 2 measurement

IGHG3 ITIH1

6.27e-056612EFO_0801810
DiseaseRectal Carcinoma

CDKN1B EGFR

8.77e-057612C0007113
DiseaseGlomerulonephritis, Membranoproliferative

C1QA CFB

8.77e-057612C0017662
Diseaseinducible T-cell costimulator measurement

IGHG3 ITIH1

8.77e-057612EFO_0021967
DiseaseRectal Neoplasms

CDKN1B EGFR

8.77e-057612C0034885
Diseasecognitive function measurement, self reported educational attainment

GALNT3 SND1 ZNF799 CLSTN2 ZNF443 ITIH1

9.25e-05355616EFO_0004784, EFO_0008354
Diseaseimmunoglobulin isotype switching measurement

IGHG2 UBR4 ITIH1

1.05e-0444613EFO_0010128
Diseaseattention deficit hyperactivity disorder, autism spectrum disorder, intelligence

GALNT3 SND1 PLCL2 ZNF799 CLSTN2 ZNF443

1.72e-04398616EFO_0003756, EFO_0003888, EFO_0004337
Diseaseaxin-2 measurement

IGHG3 ITIH1

1.87e-0410612EFO_0801400
DiseaseProstatic Intraepithelial Neoplasias

CDKN1B TOP2B

2.28e-0411612C0282612
DiseaseCongenital myopathy (disorder)

NEB RYR1

2.74e-0412612C0270960
Diseasemean corpuscular hemoglobin concentration

EGFR BZW2 HSD17B6 PLCL2 VPS13A NT5C2 NEB RHD IGDCC4

4.22e-041105619EFO_0004528
DiseaseLupus Erythematosus, Systemic

KIAA0319L C1QA CFB

4.35e-0471613C0024141
Diseaseinferior parietal cortex volume measurement

GRIK1 NT5DC1

7.03e-0419612EFO_0010307
Diseasecarpal tunnel syndrome

ADAMTS14 NT5DC1 ITIH1

8.41e-0489613EFO_0004143
Diseasepreterm premature rupture of the membranes, spontaneous preterm birth

GALNT3 ADAMTS14

1.53e-0328612EFO_0006917, MONDO_0012511
Diseasemyelodysplastic syndrome (is_implicated_in)

CDKN1B ARPC1B

1.76e-0330612DOID:0050908 (is_implicated_in)

Protein segments in the cluster

PeptideGeneStartEntry
EAILKWYKEAHVAKG

BZW2

376

Q9Y6E2
KANKHKPWIEAEYQG

CLSTN3

21

Q9BQT9
WVEKDPKKGHIYQGS

C1QA

216

P02745
DWVHYKGSLKEKTVE

NT5C2

206

P49902
SGVEDYKHFVPWCKK

COQ10B

96

Q9H8M1
EVHIYEKSGAKWTKV

ARPC1B

31

O15143
EKAAGEVSKHLYKVW

GRIK1

401

P39086
EYWDCLEGKKSKHAP

ELF3

256

P78545
NHKPLEGKYEWQEVE

CDKN1B

66

P46527
KVNKHKPWIETSYHG

CLSTN2

36

Q9H4D0
TFPVKHQVWKQKGEE

BPTF

1011

Q12830
KHSWVPYEPDDDAQK

ADAMTS14

631

Q8WXS8
NKHEDGYAAVWKGKT

IGDCC4

721

Q8TDY8
WVDKYKPETQHELAV

RAD17

91

O75943
EEPPYAIKAGWKENH

INTS6

56

Q9UL03
QKKPVRFYHDWNDKE

OLA1

196

Q9NTK5
KWNPDDYGGVKKIHI

CHRNA1

86

P02708
KGTDYHKQPWQAKIS

CFB

486

P00751
PEVLAEAYGKKEWKH

NT5DC1

96

Q5TFE4
LQKDYSKDPWHGAEV

ITIH1

871

P19827
GQGHLKKDTDWYQVK

HECA

181

Q9UBI9
EQTVKEKYEHKWPVA

LRRC7

606

Q96NW7
EKYEHKWPVAPKEIT

LRRC7

611

Q96NW7
DDKIVQYHWEELKGP

KIAA0319L

436

Q8IZA0
QGYHPNDIEKEWGKL

DST

351

Q03001
YVKSWVKGLEHDKQE

FER1L4

1521

A9Z1Z3
EWVKVVGYKGSVDHE

CANT1

246

Q8WVQ1
ESVKKHQYPDGEVWK

ENOSF1

421

Q7L5Y1
RKKNPSWTIEEYDKH

MINAR2

106

P59773
EGGYKAHAPKWESKD

NRXN3

1446

Q9Y4C0
KDKYENEDLIKHGWP

CCDC25

21

Q86WR0
EVGKHVVRWKVKFDY

MORC2

816

Q9Y6X9
VKNSKHSNKYEGWPE

FAM3A

201

P98173
EKEYHAEGGKVPIKW

EGFR

866

P00533
ETVSPDKDWYVHLVK

HTT

2091

P42858
VQKYDPDKDEWHKVF

KLHL13

606

Q9P2N7
SWKEAPKHIKETYGQ

HSD17B6

226

O14756
YKGHKTVVTGEQIWE

GALNT3

576

Q14435
KDGWKKVYDSLEPHH

DNAH7

3351

Q8WXX0
KTNFPKKGDVVHCWY

FKBP3

121

Q00688
WYVDGVEVHNAKTKP

IGHG2

156

P01859
KWYVDGVEVHNAKTK

IGHG3

206

P01860
TKPGQYWKEEVHIQD

C9orf57

61

Q5W0N0
PGYKLHWNKKDCVEV

SCUBE2

431

Q9NQ36
LDQTEHPYKSKKAVW

RYR1

3606

P21817
YSIPEFDEWKKHIEN

TOP2B

611

Q02880
GLYKQDQHWLEKKDV

SEC11B

111

P0C7V7
HKYEPSKEGQEKGWL

PLCL2

386

Q9UPR0
KQKKEKVWAHYEEQP

SND1

651

Q7KZF4
HKKQGYSNKEWPISG

STXBP5L

436

Q9Y2K9
IYKEGVKDPEDNKGW

VPS13A

416

Q96RL7
KIWKAPHEAKYFDDQ

RHD

391

Q02161
TEGEHSKEVIKPYDW

TIPRL

96

O75663
QKHYNEEEPWKRKVD

ZNF551

151

Q7Z340
WYPEGVKQHVKETKL

UBE2O

126

Q9C0C9
WNEKYGHKLDSIEGK

TTC3

941

P53804
WKKTHTGENPYGCKE

ZNF799

611

Q96GE5
EHGVYASSKEEKDWK

DHX38

141

Q92620
EILPEEVHYWKVKGS

TEX50

36

A0A1B0GTY4
KTHWKKTHTGENPYE

ZNF443

636

Q9Y2A4
GVSKVEKEHWLYPQQ

TRMT12

351

Q53H54
PLYHGFKEVEENWSK

UBR4

906

Q5T4S7
EVSDEKVTGKWYKNG

MYBPC2

461

Q14324
PKYREVWDKDKTSIH

NEB

3936

P20929